Jim Gallarda,
Senior Program Officer
Jim Gallarda, Senior Program Officer, ITS, oversees the diagnostic portfolio for the TB PST, and serves as a resource for all foundation diagnostic needs related to molecular technologies. Jim brings systems-level end-to-end thinking in diagnostic-related R&D, clinical, regulatory, and commercialization, both in the developed & developing world.
Jim has a 20-year background in industry developing in vitro diagnostics at Abbott & Roche. He is experienced in blood screening infectious disease assay development, overseeing multiple teams developing immunodiagnostic & PCR systems for HIV-1, HIV-2, HCV, HBV and WNV. Prior to joining the Bill & Melinda Gates Foundation he was with Novartis Pharmaceuticals (in Cambridge MA) leading companion diagnostics program for assays used to assess the effectiveness of tyrosine kinase inhibitors for patients with CML.
|
|
|
